Skip to content

Sight Sciences, Inc. SGHT Enterprise value

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Glaukos logo
GlaukosGKOS
$6.25B+12.5%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Bausch + Lomb logo
Bausch + LombBLCO
$10.39B+6.9%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.97B+47.8%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s enterprise value?
Sight Sciences, Inc. (SGHT) reported enterprise value of $159.53M in Q1 2026.
How has Sight Sciences, Inc.'s enterprise value changed year-over-year?
Sight Sciences, Inc.'s enterprise value increased by 190.6% year-over-year, from $54.89M to $159.53M.
What is the long-term trend for Sight Sciences, Inc.'s enterprise value?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s enterprise value has grown at a -11.8% compound annual growth rate (CAGR), from $609.32M to $368.08M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.